Tracon Pharmaceuticals Inc.
20 clinical trials · Sponsor
◉ Watch Tracon Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma (NCT05448820) | Tracon Pharmaceuticals Inc. | 2022-11-14 |
| ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma (NCT04480502) | Tracon Pharmaceuticals Inc. | 2020-12-09 |
| Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC (NCT03181308) | Tracon Pharmaceuticals Inc. | 2017-11-09 |
Track Tracon Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.